More than two-thirds of Chinese groups that have listed in the US this year have sunk below their initial public offering price, despite record levels of fundraising, as growing regulatory scrutiny hits investor sentiment.
盡管今年赴美上市中國企業募資規模達到創紀錄水平，但逾三分之二已跌破發行價，原因是不斷加大的監管審查力度打擊了投資者情緒。
您已閱讀6%（282字），剩余94%（4121字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。